Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

Presentation THT 2026

The Microtech System: Turning Implants into Smart Devices

Presenter: Yoram Richter

March 04, 2026

Presentation THT 2026

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Presenter: Issa Dahabreh

March 04, 2026

Presentation THT 2026

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Presenter: Sudhir Kushwaha

March 04, 2026

Presentation THT 2026

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Presenter: Robert W. Yeh

March 04, 2026

Presentation THT 2026

Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure

Presenter: Remi Sabatier

March 04, 2026

Presentation THT 2026

Time for a Separate Guideline Path for HF Devices?

Presenter: Javed Butler

March 04, 2026

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

Presentation THT 2026

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

Presenter: James Januzzi

March 04, 2026

Presentation THT 2026

The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies

Presenter: Gregg W. Stone

March 04, 2026

Presentation THT 2026

Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality?

Presenter: John A. Spertus

March 04, 2026

Presentation THT 2026

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Presenter: JoAnn Lindenfeld

March 04, 2026

Presentation THT 2026

Sustained Passive Physiologic Monitoring Using a Device-Agnostic AI-Enabled Platform: A Pilot Study in Chronic Heart Failure Patients

Presenter: Afnan Tariq

March 04, 2026

Presentation THT 2026

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Presenter: Makiko Nakamura

March 04, 2026

Presentation THT 2026

Intraluminal Outflow Graft Thrombus of Left Ventricular Assist Device: A Case Study

Presenter: Kinjal Banerjee

March 04, 2026

Presentation THT 2026

Approved Static Cold Preservation Devices Should Be Used in Cold Preservation

Presenter: David D'Alessandro

March 03, 2026

Presentation THT 2026

First-in-Human Use of the Elevate™ Percutaneous Left Ventricular Assist Device in Cardiogenic Shock

Presenter: David Israeli

March 03, 2026

Presentation THT 2026

The PercAssist Extravascular Ventricular Assist Device (PercAssist eVAD™ System): A Pressure-Volume Loop Evaluation of Hemodynamic Performance

Presenter: Nicolas M. Van Mieghem

March 03, 2026

Presentation THT 2026

Device Transitions — Bridge to Bridge

Presenter: Francis D. Pagani

March 03, 2026

Presentation THT 2026

Translational Validation of the SEPRDD (Sensing Pressure Releasing Diuretic Drug) - Heart Failure Device : Bridging Bench to Large Animal Models for Heart Failure Therapy

Presenter: Vasim Panwar

March 03, 2026

Presentation THT 2026

Moving Beyond a Decade of HM3: Devices of the Future

Presenter: Ivan Netuka

March 03, 2026

Advertisement

The Microtech System: Turning Implants into Smart Devices

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure

Time for a Separate Guideline Path for HF Devices?

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies

Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality?

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Sustained Passive Physiologic Monitoring Using a Device-Agnostic AI-Enabled Platform: A Pilot Study in Chronic Heart Failure Patients

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Intraluminal Outflow Graft Thrombus of Left Ventricular Assist Device: A Case Study

Approved Static Cold Preservation Devices Should Be Used in Cold Preservation

First-in-Human Use of the Elevate™ Percutaneous Left Ventricular Assist Device in Cardiogenic Shock

The PercAssist Extravascular Ventricular Assist Device (PercAssist eVAD™ System): A Pressure-Volume Loop Evaluation of Hemodynamic Performance

Device Transitions — Bridge to Bridge

Translational Validation of the SEPRDD (Sensing Pressure Releasing Diuretic Drug) - Heart Failure Device : Bridging Bench to Large Animal Models for Heart Failure Therapy

Moving Beyond a Decade of HM3: Devices of the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content